Last $18.52 USD
Change Today +0.08 / 0.43%
Volume 938.4K
As of 8:10 PM 10/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kevin C. Gorman Ph.D.

Chief Executive Officer, President and Director, Neurocrine Biosciences Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 1 different industries.

See Board Relationships
56$2,109,998
As of Fiscal Year 2013

Background*

Dr. Kevin C. Gorman, Ph.D. has been Chief Executive Officer and President of Neurocrine Biosciences Inc., since January 2008. Dr. Gorman is responsible for the in-licensing and out-licensing of technologies and products, corporate partnering activities and strategic planning. He served as Chief Business Officer and an Executive Vice President of Neurocrine Biosciences Inc. since January 2006 and also served as its Chief Operating Officer since September 2006. He served ...

Read Full Background

Corporate Headquarters*

12780 El Camino Real
San Diego, California 92130

United States

Phone: 858-617-7600
Fax: 858-617-7601

Board Members Memberships*

2008-Present
Chief Executive Officer, President and Director

Education*

PhD
University of California-Los Angeles
MBA
University of California-Los Angeles
Post-Doctoral Training
Rockefeller University

Other Affiliations*

Annual Compensation*

Salary$541,100
Bonus$178,600
Total Annual Compensation$719,700

Stock Options*

Restricted Stock Awards$259,500
All Other Compensation$38,798
Exercisable Options687,547
Exercisable Options Value$2,240,636
Unexercisable Options315,453
Unexercisable Options Value$376,964
Total Value of Options$2,617,600
Total Number of Options1,003,000

Total Compensation*

Total Annual Cash Compensation$758,498
Total Short Term Compensation$719,700
Other Long Term Compensation$298,298
Total Calculated Compensation$2,109,998
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NBIX:US $18.52 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Serge Weinberg Chairman, Interim Chief Executive Officer, Chairman of Appointments and Governance Committee and Chairman of Strategy Committee
Sanofi
€700.0K
Christophe Weber President, Chief Operating Officer and Representative Director
Takeda Pharmaceutical Company Limited
--
Glenn A. Oclassen Sr.Chairman of the Board, Chief Executive Officer and President
Transcept Pharmaceuticals, Inc.
$560.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUROCRINE BIOSCIENCES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.